Market Research Logo

World Market for Prescription Dermatological Drugs, Forecasts to 2020, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)


Attention: There is an updated edition available for this report.

World Market for Prescription Dermatological Drugs, 9th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)



The worldwide market for prescription dermatological drugs encompasses a wide variety of products that treat disorders of the skin as well as the effects of aging. It’s a very dynamic time for the prescription dermatological drug industry. Consolidation, economic times, new technologies and genetic discoveries are among the trends that the industry is seeing.

Dermatological drugs are currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded.This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the ninth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors that may help to shape the market for treatments in the future.

The driving forces for the dermatology drug market include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin. Within the pharmaceutical industry as a whole, financial depression, consolidation and economic downturns have influenced the market.

The worldwide market for prescription dermatology drugs includes products in the following categories:
  • Prescription Acne and Rosacea Drugs
  • Prescription Antiaging and Photodamage Drugs
  • Prescription Dermatitis and Seborrhea Drugs
  • Prescription Fungal Infection Drugs
  • Prescription Hair Loss and Hair Removal Drugs
  • Prescription Hyperpigmentation/Melasma Drugs
  • Prescription Psoriasis Drugs
  • Prescription Skin Cancer Drugs
  • Other Prescription Skin Disorder Drugs
This report details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription dermatological drugs in the future.

The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products. Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities. By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology. This transition will play a role in the future development of the dermatological industry over the forecast period. The worldwide pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. The sector is ripe for the picking, too, with the financial crisis having created an impressive buyer’s market for larger companies, as smaller firms struggle to extend financing. True globalization of pharmaceuticals has arrived. Most of the growth in the next few years will be outside the US, Europe and Japan. It’s a very dynamic time for the industry focusing on a worldwide market.

The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the dermatology market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 30 industry executives and product managers to validate and obtain expert opinion on current and future trends in the dermatological market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

All market data pertains to the worldwide market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2015. Historical data are provided for each of the years 2013 to 2014, and forecast data are provided for each of the years 2015 through 2020. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2015 base year.

The following companies are profiled in this report:

Allergan Inc.
Allergan Inamed Corporation
Barrier Therapeutics, Inc
Bayer AG
PharmaDerm Pharmaceuticals, Inc
Bristol-Myers Squibb
Collagenex (now Galderma) Pharmaceuticals
Galderma S.A.
Genentech, Inc.
GlaxoSmithKline Plc
Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
Medicis Pharmaceutical Corporation
Merck & Company, Inc.
Mylan Pharmaceuticals, Inc,
Novartis Pharmaceuticals Corporation
Nycomed Inc.
Pfizer, Inc.
Q-Med AB
Roche Group (F. Hoffmann-La Roche Ltd.)
Schering (now Merck)-Plough Corporation
Sinclair Pharma Plc.
SkinMedica
Stiefel Laboratories, Inc.
Valeant Pharmaceuticals, Inc.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table The Worldwide Market for Prescription Dermatological Drugs 2013, 2015, and 2020
    • ISSUES AND TRENDS AFFECTING MARKET
    • COMPETITOR ANALYSIS
  • Introduction
    • STRUCTURE AND FUNCTION OF THE SKIN
      • Epidermis
      • Dermis
      • Subcutaneous Tissue
      • Epidermal Appendages
    • FUNCTIONS OF THE SKIN
    • EFFECTS OF AGING ON THE SKIN
    • DERMATOLOGICAL CONDITIONS AND TREATMENT
    • PHARMACOKINETICS
      • Drug Absorption
      • Distribution
      • Bioavailability
    • DRUG DELIVERY METHODS
      • Table Common Bases for Topical Dermatological Medications
    • DEMOGRAPHICS OF SKIN DISORDERS, INCIDENCE, AND PREVALENCE
      • Table Worldwide Incidence and Prevalence of Selected Dermatologic Conditions
  • Issues and Trends
    • PATIENT COMPLIANCE
    • COSMETIC DERMATOLOGISTS
    • SUNSCREEN USE
    • MELANOMA SURVIVAL RATES FALTER
    • INDOOR TANNING ISSUE
    • PHOSPHATIDYLGLYCEROL AND PSORIASIS
    • NEW FILLER OPTIONS
    • CONSUMER CONFUSION
    • GENETIC LINK TO PSORIASIS
    • BIOLOGIC DERMATOLOGY
    • RX-TO-OTC SWITCHES
      • Table Selected Dermatological Rx-to-OTC Switches
    • COSMECEUTICALS
      • Antioxidants
      • Polypeptides
    • TELEDERMATOLOGY
    • REIMBURSEMENT ISSUES
      • Table Cy 2015 Relative Value Units (Rvus) and Related Information Used In Determining Final Medicare Payments
    • MARKET SHIFT TOWARDS LESS INVASIVE PROCEDURES
    • MEDI-SPAS
    • COMBINATION THERAPIES THRIVE
    • COMPETITIVE, ECONOMIC, SOCIAL FORCES DRIVING MARKET DEMAND
      • Society's Obsession with Physical Appearance
    • REGULATORY INFLUENCES: US & INTERNATIONAL
      • International Authorities
      • U.S. FDA & Other Regulatory Agencies
    • EFFECTS OF HEALTH INSURANCE PROGRAMS & TREATMENT COSTS
    • COMPETITIVE INFLUENCES—IMPACT ON MARKET & TREATMENT MODALITIES
      • Facial Skin--Bio-Physiology
      • The "Gray Areas" of Medicine
    • LASER THERAPY
    • NARROWBAND ULTRAVIOLET B
    • PHOTODYNAMIC THERAPY
    • PYCR1 GENE
    • CHANGES IN CREDIT CARD TERMS
    • PATIENT PROTECTION AND AFFORDABLE CARE ACT
    • THERMAGE
    • BRAF GENE
    • NEW ORAL MEDICATIONS AND RESEARCH FOR ACNE
    • SYNTHETIC LIPIDS FOR SKIN HEALING
    • IMPORTANCE OF DRUG DELIVERY
    • INDUSTRY CONSOLIDATION
  • Prescription Antiacne and Rosacea Drugs
    • DESCRIPTION OF DISORDERS
    • DESCRIPTION OF PRODUCTS
      • Benzoyl Peroxide
        • Table Common Benzoyl Peroxide Formulations
      • Retinoids
        • Table Common Retinoid Formulations
      • Antibiotics
        • Table Common Topical Antibiotic Formulations
      • Oral Contraceptives
        • Table Common Oral Contraceptive Formulations
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Acne, Actinic Keratosis and Rosacea Formulations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market
        • Table The Worldwide Market for Prescription Acne and Rosacea Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2013-2020
    • THE FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2015
  • Prescription Antiaging and Photodamage Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Keratolytics
        • Table Common Prescription Keratolytic Formulations
      • Moisturizers
        • Table Occlusive Moisturizers—Categories of Ingredients
        • Table Common Prescription Moisturizers
      • Retinoids
        • Table Common Prescription Retinoids for Antiaging and Photodamage
      • Sunscreens
        • Table Common Prescription Sunscreens
      • Botox and Fillers
        • Table Other Prescription Antiaging and Photodamage Products
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Antiaging and Photodamage Formulations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market
        • Table The Worldwide Market Antiaging and Photodamage Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Antiaging and Photodamage Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Antiaging and Photodamage Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 2013-2020
    • THE FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2015
  • Prescription Dermatitis and Seborrhea Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Topical Corticosteroids
        • Table Common Prescription Topical Corticosteroid Preparations
      • Systemic Corticosteroids
        • Table Common Prescription Systemic Corticosteroids
      • Other Products
        • Table Prescription Other Dermatitis Formulations
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Dermatitis Formulations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market by Type
        • Table The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Dermatitis and Seborrhea Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Dermatitis and Seborrhea Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 2013-2020
    • FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Dermatitis and Seborrhea Drugs, Revenues and Market Share by Supplier 2015
  • Prescription Antifungal Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Systemic Formulations
        • Table Common Prescription Systemic Antifungal Dermatological Formulations
      • Topical Formulations
        • Table Common Prescription Topical Antifungal Dermatological Drugs
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Antifungal Dermatological Drugs in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market by Type
        • Table The Worldwide Market for Prescription Antifungal Dermatological Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Dermatological Antifungal Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Dermatological Antifungal Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2013-2020
    • FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2015
  • Prescription Hair Loss and Hair Removal Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Antiandrogens
      • Androgen Inhibitors
      • Other Treatments
        • Table Common Prescription Hair Loss or Hair Removal Formulations
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Hair Loss or Hair Removal Formulations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market by Type
        • Table The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Dermatological Hair Loss and Hair Removal Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Dermatological Hair Loss and Hair Removal Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Hair Loss and Hair Removal Drugs, Revenues by Geographical Region 2013-2020
    • FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2015
  • Prescription Hyperpigmentation/Melasma and Depigmenting Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Table Common Prescription Hyperpigmentation/Melasma Formulations
      • Table Common Prescription Depigmenting Agents
    • MARKET SIZE AND GROWTH
      • Worldwide Market
        • Table The Worldwide Market for Prescription Hyperpigmentation/Melasma and Depigmenting Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table The Worldwide Market for Prescription Hyperpigmentation/Melasma Drugs by Geographical Region 2013-2020
    • RESEARCH AND DEVELOPMENT
    • THE FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
  • Prescription Psoriasis Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Selected Topical Psoriasis Products
      • Selected Systemic Psoriasis Preparations
        • Table Selected Common Prescription Psoriasis Preparations
      • Light Therapy
      • Biologics
        • Table Common Prescription Biologics for Psoriasis Treatment
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Psoriasis Preparations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market by Type
        • Table The Worldwide Market for Prescription Psoriasis Drugs by Type 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Psoriasis Drugs by Geographical Region 2013-2020
    • FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2015
  • Prescription Skin Cancer Drugs
    • OVERVIEW
      • Nonmelanoma Skin Cancers
        • Table Malignant Conditions of the Skin
      • Malignant Melanoma
    • DESCRIPTION OF PRODUCTS
      • 5-Fluorouracil
      • Mechlorethamine/Nitrogen Mustard
      • Carmustine/BCNU (Topical)
      • Vinblastine (Intralesional) and Others
        • Table Common Prescription Topical, Intralesional and Other Skin Cancer Agents
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Skin Cancer Preparations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market
        • Table The Worldwide Market for Skin Cancer Drugs 2013-2020
      • Markets by Geographical Region
        • Table Top Five EU Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)
        • Table Top Four Rest of World Countries Prescription Psoriasis Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Skin Cancer Drugs by Geographical Region 2013-2020
    • THE FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2015
  • Miscellaneous Skin Disorder Drugs
    • OVERVIEW
      • Antivirals
      • Antiparasitics
    • DESCRIPTION OF PRODUCTS
      • Antivirals
        • Table Common Prescription Dermatological Systemic and Topical Antiviral Formulations
      • Antiparasitic Agents
        • Table Common Prescription Topical Antiparasitic Formulations
    • OTHER SKIN RELATED PRODUCTS
      • Table Common Prescription Other Skin Formulations
    • RESEARCH AND DEVELOPMENT
      • Table Prescription Miscellaneous Skin Preparations in Development
    • MARKET SIZE AND GROWTH
      • Worldwide Market
        • Table The Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Type 2013-2020
    • MARKETS BY GEOGRAPHICAL REGION
      • United States
      • Europe
        • Table Top Five EU Countries Prescription Miscellaneous Skin Disorder Drug Markets by Revenues and Percent 2015 (in millions $)
      • Japan
      • Rest of World
        • Table Top Four Rest of World Countries Prescription Miscellaneous Skin Disorder Drug Markets by Revenues and Percent 2015 (in millions $)
        • Table The Worldwide Market for Prescription Miscellaneous Skin Disorder Drugs by Geographical Region 2013-2020
    • THE FUTURE OF THE MARKET
    • COMPETITIVE ANALYSIS
  • World Market Summary
    • OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table The Worldwide Market for Prescription Dermatological Drugs, Revenues by Segment, 2013-2020
    • MARKET ANALYSIS BY COUNTRY
      • United States
      • Europe
      • Japan
      • Rest of World
        • Table Worldwide Prescription Dermatological Drug Market Analysis by Region/Country, 2015
    • MARKET AND COMPETITIVE ANALYSIS
      • Table Worldwide Market for Prescription Dermatological Drugs Segments of Major Participation by Manufacturer 2015
      • Table Worldwide Market for Prescription Dermatological Drug Revenues and Market Share by Supplier 2015
  • Corporate Profiles
    • ABBVIE, INC.
    • ALLERGAN
    • AMGEN, INC.
    • ANACOR PHARMACEUTICALS, INC.
    • ASTELLAS PHARMA, INC.
    • BAYER AG
    • BRISTOL-MYERS SQUIBB
    • GALDERMA S.A.
    • GENENTECH, INC.
    • GLAXOSMITHKLINE PLC
    • JOHNSON & JOHNSON
    • MERCK & COMPANY, INC.
    • MYLAN N.V
    • NOVARTIS PHARMACEUTICALS CORPORATION
    • PFIZER, INC.
    • PHARMADERM
    • STIEFEL
    • SINCLAIR IS PHARMA PLC.
    • STRATUS PHARMACEUTICALS, INC.
    • VALEANT PHARMACEUTICALS INTERNATIONAL
  • APPENDIX
    • List of Companies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report